Durham County total closed sales were up more than 16 percent in April compared to the same month last year, but the county’s average and median home sale prices were both down.
Brady becomes licensed architect
Wearing sunglasses to protect their eyes, political officials and others toured Syngenta Biotechnology’s new $72 million greenhouse and laboratory facility in the Research Triangle Park on Friday where corn and other crops are already growing to test the facility’s plant growing conditions.
CED launches website for entrepreneurs
A pop-up exhibit focused on the history of Durham-based N.C. Mutual Life Insurance Co. will be held Sunday at the Durham History Hub.
The free, public exhibit is sponsored by the company in anticipation of its 115-year anniversary, along with the Museum of Durham History.
The sponsors have invited people with a connection to the company to bring memorabilia and tell stories.
For the most part, the pressure washer that Durham resident Eric Boggs bought a few years ago has been sitting in his basement, collecting dust, he said.
MHAworks announces project designer
Consulting firm employee joins DiabetesSisters board
Two elected to Research Triangle Foundation board
The Herald-Sun plans to sell its 23-year-old building at 2828 Pickett Road and build or lease smaller space elsewhere in Durham.
Information technology job openings in North Carolina were down 28 percent to a total of 3,960 in April compared to the same month last year. They nearly held steady with March, with a 0.8 percent gain.
A groundbreaking ceremony will be Wednesday for the $46.1 million collegiate apartment complex now known as 605 West at 605 W. Chapel Hill St. in Durham.
Building permits filed in the city and county of Durham in the 10-month period through April were up 40 percent year-over-year, according to Durham City-County Building and Inspections data.
Durham-based Quintiles Transnational Holdings Inc.’s stock was trading up about 5 percent at the market’s close on Thursday in the first day of trading on the New York Stock Exchange for the biopharmaceutical services company.
Durham-based Quintiles Transnational Holdings Inc.’s stock was trading up more than 9 percent on the New York Stock Exchange close to midday Thursday in the second public debut for the company, which manages clinical trials for drug development firms.
Durham-based Quintiles announced that it will offer its common stock for purchase by the public at a price of $40 on Thursday, when its stock starts trading on the New York Stock Exchange.
The company’s major business is in the management of clinical trials and associated laboratory and analysis work for pharmaceutical companies. It also provides contract drug sales, among other services.